Rosenthal pointed out that science is presently experiencing a rapid
development of new technologies and methods. For instance, new high-throughput
methods can produce amazing amounts of data in very short time periods that
were not even conceivable 10 years ago. “These methods not only open up
hitherto fore unimagined possibilities; but also bring with them new and
same time, Professor Rosenthal also emphasized that the molecular medical
research of the MDC was to have as its final focus on projects involving normal
human volunteers and patients. For that reason, the MDC and the Charité will
continued their joint cooperative effort in terms of the Experimental and
Clinical Research Center (ECRC ). The ECRC has an own section within the report.
Furthermore, numerous MDC research groups have direct cooperative interactions
with the ECRC.
research report contains overviews of the MDC’s main research areas in German
and English. The reports of the individual research groups, which are primarily
for intended for interested scientists, are in English.
was founded on the Berlin-Buch Campus in 1992. It is a member of the Helmholtz
Association of German Research Centers and receives its basic operational funding
of approximately 61 million euros a year in a fixed ratio of 90 percent from
the Federal Ministry of Education and Research and 10 percent from the province of Berlin. In addition, extramural grants
acquired by the researchers total more than 20 million euros a year.
present, 1380 people work at the MDC including about 1120 scientists. Of these
scientists, 420 are guest researchers. The MDC cooperates closely with the
Charité, the Leibniz Institute for Molecular Pharmacology (FMP), and the
biotechnology park on Campus Berlin-Buch with its 47 companies and 740
employees. Altogether, more than 2200 people work on the Berlin-Buch campus.
this new research report, please request a copy from the MDC Press Office.
and Public Affairs
Center for Molecular Medicine (MDC)
13125 Berlin; Germany
+49 (0) 30 94 06 - 38 96
Fax: +49 (0) 30 94 06 - 38 33